To study the effect of drug VELLARUGU CHOORANAM on Gunman (peptic ulcer)
- Conditions
- ERIGUNMAM
- Registration Number
- CTRI/2018/04/012924
- Lead Sponsor
- Dr S Neelavathi MD siddha PhD
- Brief Summary
The study is prospective open Labeled non randomized phase II clinical trial to evaluate the therapeutic efficacy of trial drug Vellarugu Chooranam 30mg/kg/BW/two times a day with warm water for 30 days in 40 patients during the trial period of 15 months that will be conducted in Government Siddha Medical college and hospital Palayamkottai Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug Vellarugu Chooranam on ERIGUNMAM The secondary outcome will be the evaluation of Siddha diagnostic parameters
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Patient with appropriate symptoms of burning pain in upper abdomen nausea waterbrash headache flatulence dizziness excessive sweating loss of body weight lack of food intake neuritic pain cough patient who are willing to sign consent form and undergo laboratory investigations.
Pregnant and lactating women haemetemesis Malena pancreatitis inflammatory bowel disease recent malignancy or radiation therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic efficacy of trial drug VELLARUGU CHOORANAM on ERIGUNMAM 30 days
- Secondary Outcome Measures
Name Time Method Evaluation of siddha diagnostic parameters 30 days
Trial Locations
- Locations (1)
Government Siddha Medical College and Hospital
🇮🇳Tirunelveli, TAMIL NADU, India
Government Siddha Medical College and Hospital🇮🇳Tirunelveli, TAMIL NADU, IndiaM MUTHUMARIPrincipal investigator8220606063dr.muthumari23@gmail.com